These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 27363205)
21. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity. Lee BK; Kwon JS; Kim HJ; Yamamoto S; Lee EK Bioconjug Chem; 2007; 18(6):1728-34. PubMed ID: 17941681 [TBL] [Abstract][Full Text] [Related]
22. Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b. Lee JI; Eisenberg SP; Rosendahl MS; Chlipala EA; Brown JD; Doherty DH; Cox GN J Interferon Cytokine Res; 2013 Dec; 33(12):769-77. PubMed ID: 23962003 [TBL] [Abstract][Full Text] [Related]
31. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography. Qin X; Li J; Li Y; Gan Y; Huang H; Liang C J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672 [TBL] [Abstract][Full Text] [Related]
32. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group. Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804 [TBL] [Abstract][Full Text] [Related]
33. Rational surface engineering of an arginine deiminase (an antitumor enzyme) for increased PEGylation efficiency. Cheng F; Yang J; Schwaneberg U; Zhu L Biotechnol Bioeng; 2019 Sep; 116(9):2156-2166. PubMed ID: 31062871 [TBL] [Abstract][Full Text] [Related]
34. Separation and detection of bis-maleimide-polyethylene glycol and mono-maleimide-polyethylene glycol by reversed-phase high pressure liquid chromatography. Tang L; Jariwala F; Bolgar M; Lloyd DK J Chromatogr A; 2012 Jul; 1246():117-22. PubMed ID: 22503616 [TBL] [Abstract][Full Text] [Related]
35. Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin. Nie Y; Zhang X; Wang X; Chen J Bioconjug Chem; 2006; 17(4):995-9. PubMed ID: 16848407 [TBL] [Abstract][Full Text] [Related]
36. Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification. Karbasian M; Kouchakzadeh H; Anamaghi PN; Sefidbakht Y Int J Pharm; 2019 Feb; 557():9-17. PubMed ID: 30576790 [TBL] [Abstract][Full Text] [Related]
37. Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity. Osipovitch DC; Therrien S; Griswold KE Appl Microbiol Biotechnol; 2015 Aug; 99(15):6315-26. PubMed ID: 25690309 [TBL] [Abstract][Full Text] [Related]
38. Conformational stability of lyophilized PEGylated proteins in a phase-separating system. Heller MC; Carpenter JF; Randolph TW J Pharm Sci; 1999 Jan; 88(1):58-64. PubMed ID: 9874703 [TBL] [Abstract][Full Text] [Related]
39. Chemical and enzymatic site specific PEGylation of hGH. da Silva Freitas D; Mero A; Pasut G Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141 [TBL] [Abstract][Full Text] [Related]
40. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment. Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]